US Revenue Cycle Management Market Size At Around US$ 312 Bn In 2030

The US revenue cycle management market would grow at a CAGR of 10.24% over the predicted time frame. The market is expected to increase in value from US$ 142.99 Bn in 2022 to US$ 312 Bn in 2030.

The on US revenue cycle management Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.

Download Free Sample@ https://www.precedenceresearch.com/sample/2431

A recent report provides crucial insights along with application based and forecast information in the Global US revenue cycle management Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the US revenue cycle management market.

A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.

Companies and Manufacturers Covered

The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global US revenue cycle management market are included as given below:

US revenue cycle management Market Key Players

• Allscripts Healthcare Solutions 
• Change Healthcare Inc.
• Cognizant Technology Solutions Corp.
• Computer Programs and Systems Inc.
• Experian Plc
• Medical Information Technology Inc.
• MEDIREVV
• OSP Labs
• Quest Diagnostics Inc.
• R1 RCM Inc.

Market Segments

By Product

• Software
• Services

By Type

• Integrated 
• Standalone

By Function

• Product Development
• Member Engagement
• Network Management
• Care Management
• Claims Management
• Risk and Compliances

By Delivery Mode

• Web based
• Cloud based

By Physician Specialty

• Oncology
• Cardiology
• Anesthesia
• Radiology
• Pathology
• Pain Management
• Emergency Service
• Others

By Sourcing

• In-house
• External RCM Apps/ Software
• Outsourced RCM Services

By End User

• Physician Back office,
• Hospitals
• Diagnostic Laboratories
• Other

Report Objectives

• To define, describe, and forecast the global US revenue cycle management market based on product, and region
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
• To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
• To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
• To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
• To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
• To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the US revenue cycle management market

Table of Content

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on US Revenue Cycle Management Market 

5.1. COVID-19 Landscape: US Revenue Cycle Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global US Revenue Cycle Management Market, By Function

8.1. US Revenue Cycle Management Market, by Function, 2022-2030

8.1.1. Product Development

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Member Engagement

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Network Management

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Care Management

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Claims Management

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Risk and Compliances

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global US Revenue Cycle Management Market, By Product

9.1. US Revenue Cycle Management Market, by Product, 2022-2030

9.1.1. Software

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Services

Chapter 10. Global US Revenue Cycle Management Market, By Type 

10.1. US Revenue Cycle Management Market, by Type, 2022-2030

10.1.1. Integrated

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Standalone

Chapter 11. Global US Revenue Cycle Management Market, By Delivery Mode

11.1. US Revenue Cycle Management Market, by Delivery Mode, 2022-2030

11.1.1. Web based

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Cloud based

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global US Revenue Cycle Management Market, By End User

12.1. US Revenue Cycle Management Market, by End User, 2022-2030

12.1.1. Physician Back office

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Hospitals

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Diagnostic Laboratories

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Other

12.1.4.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global US Revenue Cycle Management Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.5. Market Revenue and Forecast, by End User (2017-2030)

13.1.6. U.S.

13.1.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.6.5. Market Revenue and Forecast, by End User (2017-2030) 

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Forecast, by Function (2017-2030)

13.1.7.2. Market Revenue and Forecast, by Product (2017-2030)

13.1.7.3. Market Revenue and Forecast, by Type (2017-2030)

13.1.7.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.1.7.5. Market Revenue and Forecast, by End User (2017-2030)

13.2. Europe

13.2.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.4. Market Revenue and Forecast, by Delivery Mode (2017-2030) 

13.2.5. Market Revenue and Forecast, by End User (2017-2030) 

13.2.6. UK

13.2.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.7. Market Revenue and Forecast, by Delivery Mode (2017-2030) 

13.2.8. Market Revenue and Forecast, by End User (2017-2030) 

13.2.9. Germany

13.2.9.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.9.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.9.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.10. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.11. Market Revenue and Forecast, by End User (2017-2030)

13.2.12. France

13.2.12.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.12.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.12.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.12.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.13. Market Revenue and Forecast, by End User (2017-2030)

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Forecast, by Function (2017-2030)

13.2.14.2. Market Revenue and Forecast, by Product (2017-2030)

13.2.14.3. Market Revenue and Forecast, by Type (2017-2030)

13.2.14.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.2.15. Market Revenue and Forecast, by End User (2017-2030)

13.3. APAC

13.3.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.6. India

13.3.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.7. Market Revenue and Forecast, by End User (2017-2030)

13.3.8. China

13.3.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.9. Market Revenue and Forecast, by End User (2017-2030)

13.3.10. Japan

13.3.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.3.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.3.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.3.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.3.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.4. MEA

13.4.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.6. GCC

13.4.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.7. Market Revenue and Forecast, by End User (2017-2030)

13.4.8. North Africa

13.4.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.9. Market Revenue and Forecast, by End User (2017-2030)

13.4.10. South Africa

13.4.10.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.10.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.10.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.10.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.10.5. Market Revenue and Forecast, by End User (2017-2030)

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Forecast, by Function (2017-2030)

13.4.11.2. Market Revenue and Forecast, by Product (2017-2030)

13.4.11.3. Market Revenue and Forecast, by Type (2017-2030)

13.4.11.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.4.11.5. Market Revenue and Forecast, by End User (2017-2030)

13.5. Latin America

13.5.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.5. Market Revenue and Forecast, by End User (2017-2030)

13.5.6. Brazil

13.5.6.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.6.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.6.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.6.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.7. Market Revenue and Forecast, by End User (2017-2030)

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Forecast, by Function (2017-2030)

13.5.8.2. Market Revenue and Forecast, by Product (2017-2030)

13.5.8.3. Market Revenue and Forecast, by Type (2017-2030)

13.5.8.4. Market Revenue and Forecast, by Delivery Mode (2017-2030)

13.5.8.5. Market Revenue and Forecast, by End User (2017-2030)

Chapter 14. Company Profiles

14.1. Allscripts Healthcare Solutions

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Change Healthcare Inc.

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Cognizant Technology Solutions Corp.

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Computer Programs and Systems Inc.

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Experian Plc

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Medical Information Technology Inc.

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. MEDIREVV

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. OSP Labs

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Quest Diagnostics Inc.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. R1 RCM Inc.

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

Contact Us:

Precedence Research

Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada

Call: +1 774 402 6168

Email: sales@precedenceresearch.com

Website: https://www.precedenceresearch.com

 Blog: https://www.pharma-geek.com